Mark Dahlby is a highly skilled and experienced attorney with a focus on FDA regulatory, compliance, strategy, commercial, and market-access issues impacting the life sciences and healthcare industries, as well as developers of software, medical devices, and pharmaceuticals. Dahlby is a graduate of the University of Wisconsin-Madison Law School and has a bachelor's degree in business management and political science. With impressive experience in legal practice and a passion for innovations involving digital health, artificial intelligence, blockchain, and cloud-based technologies, he has earned recognition as the Chief FDA Regulatory and Healthcare Compliance Counsel at IBM.

Besides, Dahlby has had previous experience working as lead brand counsel and regulatory compliance initiatives, intelligence, and strategy at GE Healthcare. He is also a former board member at BioForward, served as an attorney at Hall Render Killian Heath & Lyman, and as a noncommissioned officer in the United States Marine Corps 2nd Light Armored Recon. Dahlby's background makes him a seasoned pro in his field and an asset to any organization he works with.